Navigation Links
Novel therapeutic strategy for colon cancer treatment

A team of scientists at the Genome Institute of Singapore (GIS), a research institute of the Asian city-state's Agency for Science, Technology and Research (A*STAR), and the University of California at San Francisco have developed a pharmacological approach to kill colon cancer cells.

Genetic and epigenetic defects in the signaling of a protein called Wnt/β-catenin, which is often found to be abnormally activated in human malignance, play important roles in colorectal cancer development. The team of scientists identified a gene, called DACT3, whose function is to inhibit Wnt/β-catenin, is often lost (or transcriptionally silenced) in colorectal cancer.

Apart from the findings on DACT3, they have also developed a pharmacological approach to restore the expression of DACT3, which results in the effective inhibition of Wnt/β-catenin massive death of colon cancer cells. Their discovery was published in Cancer Cell on June 9, 2008.

GIS Group Leader, Yu Qiang, Ph.D., said, "This work identifies a significant new regulator of the Wnt/β-catenin avenue for future colorectal cancer research."

Edison Liu, M.D., Executive Director of GIS, added, "This is indeed a very significant discovery. It suggests a novel therapy for colorectal cancer, an important step towards clinical treatment for the disease, which is one of the leading causes of death from tumours."

The team is now working with other A*STAR research institutes and industry partners for the development of potential drug candidates based on this technology.


Contact: Cathy Yarbrough
Agency for Science, Technology and Research (A*STAR), Singapore

Page: 1

Related biology news :

1. A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice
2. Jefferson receives $11.6M NIH grant to study novel mechanisms of heart failure
3. Glypican-3 gene function in regulating body size helps inform novel cancer treatments
4. Novel living system recreates predator-prey interaction
5. UD researchers discover novel gene toggles in worlds top food crop
6. Workman Lab characterizes novel regulator of chromosome function
7. Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants
8. NIA uses Genomatix in stem cell research, suggests novel transcription factors for stemness
9. UDs Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals
10. Scientists outline novel approach to ecosystem management
11. Systems biologist finds novel solutions to fundamental biological problems
Post Your Comments:
(Date:10/6/2015)... 6, 2015  Maverix Biomics, Inc., a leading ... its software portfolio with the debut of its ... expression in eukaryotes. The software is integrated into ... genomic analysis solution that leverages proven open-source algorithms ... sequencing efforts. Garry Nolan,s laboratory ...
(Date:9/30/2015)... , Sept. 30, 2015  With nearly 300,000 ... number of new SCIs estimated to reach 12,500 annually, ... Southern California Resource Services for Independent Living (SCRS-IL) ... in California opening doors to ... of programs and services, notably assistive technology services and ...
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... ... ... Clinovo recently appointed Jeff Parr and Ed Donaldson to its Business Development Management ... Jeff Parr has spent the past decade providing quality management software and consulting services ... Sciex to name a few. He is based in Salt Lake City, a ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... technologies, announced today that it received de novo clearance from the U.S. Food ... for the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic ...
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, ... announce their partnership with the Keck Medicine of the University of Southern ... The T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic ...
(Date:10/13/2015)... Jersey (PRWEB) , ... October 13, 2015 , ... ... enhance the educational opportunities for school age children in the areas of Science, ... for all sectors of the national economy, and the program aims to increase ...
Breaking Biology Technology: